Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer
Lucy Gately,Azim Jalali,Christine Semira,Ian Faragher,Matthew Croxford,Sumitra Ananda,Suzanne Kosmider,Kathryn Field,Sheau Wen Lok,Grace Gard,Malcolm Steel,Margaret Lee,Rachel Wong,Hui-Li Wong,Peter Gibbs
DOI: https://doi.org/10.1080/0284186x.2021.1943519
IF: 4.311
2021-06-29
Acta Oncologica
Abstract:BACKGROUND: Multiple meta-analyses have demonstrated that routine surveillance following colorectal cancer surgery improves survival outcomes. There is limited data on how recurrence patterns and post-recurrence outcomes vary by individual tumor stage.METHODS: Using a multi-site community cohort study, we examined the potential impact of primary tumor stage on the sites of recurrence, management of recurrent disease with curative intent, and post-resection survival. We also explored changes over time.RESULTS: Of 4257 new colon cancers diagnosed 2001 through 2016, 789 (21.1%) had stage I, 1584 (42.4%) had stage II, and 1360 (36.4%) had stage III colon cancer. For consecutive 5-year periods (2001-2005, 2006-2010, 2011-2016), recurrence rates have declined (23.4 <i>vs.</i> 17.1 <i>vs.</i> 13.6%, <i>p</i> < 0.001), however, the resection rates of metastatic disease (29.3 <i>vs.</i> 38.6 <i>vs.</i> 35.0%, <i>p</i> = 0.21) and post-resection 5-year survival (52.0 <i>vs.</i> 51.8 <i>vs.</i> 64.2%, <i>p</i> = 0.12) have remained steady. Primary tumor stage impacted recurrence rate (3.8 <i>vs.</i> 12 <i>vs.</i> 28%, <i>p</i> < 0.0001 for stage 1, 2, and 3), patterns of recurrence, resection of metastatic disease, (50 <i>vs.</i> 42 <i>vs.</i> 30%, <i>p</i> < 0.0001) and post-resection 5-year survival (92 <i>vs.</i> 64 <i>vs.</i> 44%, <i>p</i> < 0.001).CONCLUSION: In this community cohort we defined significant differences in recurrence patterns and post-resection survival by tumor stage, with a diminishing rate of recurrence over time. While recurrence rates were lower with stage I and II disease, the high rate of metastatic disease resection and excellent post-resection outcomes help to justify routine surveillance in these patients.
oncology